2387 related articles for article (PubMed ID: 18472316)
1. Colectomy rate in acute severe ulcerative colitis in the infliximab era.
Aratari A; Papi C; Clemente V; Moretti A; Luchetti R; Koch M; Capurso L; Caprilli R
Dig Liver Dis; 2008 Oct; 40(10):821-6. PubMed ID: 18472316
[TBL] [Abstract][Full Text] [Related]
2. Infliximab as a rescue therapy for hospitalized patients with severe ulcerative colitis refractory to systemic corticosteroids.
Yamamoto-Furusho JK; Uzcanga LF
Dig Surg; 2008; 25(5):383-6. PubMed ID: 19005257
[TBL] [Abstract][Full Text] [Related]
3. Outcome of a conservative approach in severe ulcerative colitis.
Daperno M; Sostegni R; Scaglione N; Ercole E; Rigazio C; Rocca R; Pera A
Dig Liver Dis; 2004 Jan; 36(1):21-8. PubMed ID: 14971812
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and safety of infliximab as rescue therapy for ulcerative colitis refractory to tacrolimus.
Yamamoto S; Nakase H; Matsuura M; Honzawa Y; Masuda S; Inui K; Chiba T
J Gastroenterol Hepatol; 2010 May; 25(5):886-91. PubMed ID: 20546441
[TBL] [Abstract][Full Text] [Related]
5. Infliximab for the treatment of ulcerative colitis: outcomes in Oxford from 2000 to 2006.
Jakobovits SL; Jewell DP; Travis SP
Aliment Pharmacol Ther; 2007 May; 25(9):1055-60. PubMed ID: 17439506
[TBL] [Abstract][Full Text] [Related]
6. A retrospective analysis of the efficacy and safety of infliximab as rescue therapy in acute severe ulcerative colitis.
Lees CW; Heys D; Ho GT; Noble CL; Shand AG; Mowat C; Boulton-Jones R; Williams A; Church N; Satsangi J; Arnott ID;
Aliment Pharmacol Ther; 2007 Aug; 26(3):411-9. PubMed ID: 17635376
[TBL] [Abstract][Full Text] [Related]
7. Infliximab in severe ulcerative colitis: short-term results of different infusion regimens and long-term follow-up.
Kohn A; Daperno M; Armuzzi A; Cappello M; Biancone L; Orlando A; Viscido A; Annese V; Riegler G; Meucci G; Marrollo M; Sostegni R; Gasbarrini A; Peralta S; Prantera C
Aliment Pharmacol Ther; 2007 Sep; 26(5):747-56. PubMed ID: 17697208
[TBL] [Abstract][Full Text] [Related]
8. Current management of severe ulcerative colitis.
Caprilli R; Viscido A; Latella G
Nat Clin Pract Gastroenterol Hepatol; 2007 Feb; 4(2):92-101. PubMed ID: 17268544
[TBL] [Abstract][Full Text] [Related]
9. Infliximab for ulcerative colitis in children and adolescents.
McGinnis JK; Murray KF
J Clin Gastroenterol; 2008 Sep; 42(8):875-9. PubMed ID: 18645529
[TBL] [Abstract][Full Text] [Related]
10. A review of infliximab use in ulcerative colitis.
Wilhelm SM; McKenney KA; Rivait KN; Kale-Pradhan PB
Clin Ther; 2008 Feb; 30(2):223-30. PubMed ID: 18343261
[TBL] [Abstract][Full Text] [Related]
11. Infliximab or cyclosporine for acute severe ulcerative colitis: a retrospective analysis.
Dean KE; Hikaka J; Huakau JT; Walmsley RS
J Gastroenterol Hepatol; 2012 Mar; 27(3):487-92. PubMed ID: 22098019
[TBL] [Abstract][Full Text] [Related]
12. [Infliximab in moderate to severe steroid-dependent or steroid-refractory ulcerative colitis].
Mocciaro F; Orlando A; Scimeca D; Cottone M
Recenti Prog Med; 2007 Nov; 98(11):560-4. PubMed ID: 18044405
[TBL] [Abstract][Full Text] [Related]
13. Long-term colectomy rate after intensive intravenous corticosteroid therapy for ulcerative colitis prior to the immunosuppressive treatment era.
Gustavsson A; Halfvarson J; Magnuson A; Sandberg-Gertzén H; Tysk C; Järnerot G
Am J Gastroenterol; 2007 Nov; 102(11):2513-9. PubMed ID: 17680849
[TBL] [Abstract][Full Text] [Related]
14. Cyclosporine and infliximab as rescue therapy for each other in patients with steroid-refractory ulcerative colitis.
Maser EA; Deconda D; Lichtiger S; Ullman T; Present DH; Kornbluth A
Clin Gastroenterol Hepatol; 2008 Oct; 6(10):1112-6. PubMed ID: 18928936
[TBL] [Abstract][Full Text] [Related]
15. Response to first intravenous steroid therapy determines the subsequent risk of colectomy in ulcerative colitis patients.
Molnár T; Farkas K; Nyári T; Szepes Z; Nagy F; Wittmann T
J Gastrointestin Liver Dis; 2011 Dec; 20(4):359-63. PubMed ID: 22187700
[TBL] [Abstract][Full Text] [Related]
16. Long-term effects and colectomy rates in ulcerative colitis patients treated with infliximab: a Danish single center experience.
Teisner AS; Ainsworth MA; Brynskov J
Scand J Gastroenterol; 2010 Dec; 45(12):1457-63. PubMed ID: 20701434
[TBL] [Abstract][Full Text] [Related]
17. Experience of maintenance infliximab therapy for refractory ulcerative colitis from six centres in England.
Russo EA; Harris AW; Campbell S; Lindsay J; Hart A; Arebi N; Milestone A; Tsai HH; Walters J; Carpani M; Westaby D; Thillainayagam A; Bansi D; Ghosh S
Aliment Pharmacol Ther; 2009 Feb; 29(3):308-14. PubMed ID: 19035973
[TBL] [Abstract][Full Text] [Related]
18. Short- and long-term response to and weaning from infliximab therapy in pediatric ulcerative colitis.
Fanjiang G; Russell GH; Katz AJ
J Pediatr Gastroenterol Nutr; 2007 Mar; 44(3):312-7. PubMed ID: 17325550
[TBL] [Abstract][Full Text] [Related]
19. Does infliximab influence surgical morbidity of ileal pouch-anal anastomosis in patients with ulcerative colitis?
Schluender SJ; Ippoliti A; Dubinsky M; Vasiliauskas EA; Papadakis KA; Mei L; Targan SR; Fleshner PR
Dis Colon Rectum; 2007 Nov; 50(11):1747-53. PubMed ID: 17704969
[TBL] [Abstract][Full Text] [Related]
20. Infliximab salvage therapy after failure of ciclosporin in corticosteroid-refractory ulcerative colitis: a multicentre study.
Chaparro M; Burgueño P; Iglesias E; Panés J; Muñoz F; Bastida G; Castro L; Jiménez C; Mendoza JL; Barreiro-de Acosta M; Senent SG; Gomollón F; Calvet X; García-Planella E; Gómez M; Hernández V; Hinojosa J; Mañosa M; Nyssen OP; Gisbert JP
Aliment Pharmacol Ther; 2012 Jan; 35(2):275-83. PubMed ID: 22142227
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]